Publication Name	World Journal of Clinical Cases
Manuscript ID	67011
Country	China

Received	2021-04-15 15:16
Peer-Review Started	2021-04-15 15:18
To Make the First Decision
Return for Revision	2021-07-06 01:20
Revised	2021-07-08 04:21
Second Decision	2021-09-08 03:00
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-09-08 10:21
Articles in Press	2021-09-08 10:21
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-12-08 17:32
Typeset the Manuscript	2022-01-17 01:06
Publish the Manuscript Online	2022-01-24 08:11

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Sintilimab-induced autoimmune diabetes: A case report and review of the literature
Manuscript Source	Unsolicited Manuscript
All Author List	Jing Yang, Ying Wang and Xiang-Min Tong
ORCID	Author(s) ORCID Number Jing Yang http://orcid.org/0000-0002-7439-4802 Ying Wang http://orcid.org/0000-0003-2121-7025 Xiang-Min Tong http://orcid.org/0000-0002-4175-0321
Funding Agency and Grant Number	Funding Agency Grant Number Key Research and Development Project of Science and Technology Department of Zhejiang Province 2019C03038
Corresponding Author	Xiang-Min Tong, MD, PhD, Chief Physician, Department of Hematology, Clinical Trial Institute, Zhejiang Provincial People's Hospital, No. 158 Shangtang Road, Hangzhou 310014, Zhejiang Province, China. tongxiangmin@163.com
Key Words	Sintilimab; Immune related adverse effects; Small cell lung cancer; Autoimmune diabetes; Case report
Core Tip	We report a case of programmed cell death-1 (PD-1) inhibitor-induced autoimmune diabetes mellitus (DM) after treatment of small cell lung cancer, and reviewed some published cases (n = 36) of PD-1/PD-ligand 1 inhibitor-induced DM. Plasma glucose monitoring is significant for preventing the occurrence of diabetic ketoacidosis.
Publish Date	2022-01-24 08:11
Citation	Yang J, Wang Y, Tong XM. Sintilimab-induced autoimmune diabetes: A case report and review of the literature. World J Clin Cases 2022; 10(4): 1263-1277
URL	https://www.wjgnet.com/2307-8960/full/v10/i4/1263.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i4.1263

Full Article (PDF)	WJCC-10-1263.pdf
Full Article (Word)	WJCC-10-1263.docx
CARE Checklist–2016	67011-CARE-Checklist–2016-revision.jpg
Manuscript File	67011_Auto_Edited_Kerr C_Clear Copy.docx
Answering Reviewers	67011-Answering reviewers.pdf
Audio Core Tip	67011-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	67011-Conflict-of-interest statement.pdf
Copyright License Agreement	67011-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	67011-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	67011-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	67011-Language certificate.pdf
Peer-review Report	67011-Peer-review(s).pdf
Scientific Editor Work List	67011-Scientific editor work list.pdf
CrossCheck Report	67011-CrossCheck report.pdf